Crescent Capital BDC, Inc. (NASDAQ:CCAP) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP) have earned an average recommendation of “Moderate Buy” from the six research firms that are covering the company, Marketbeat.com reports. One analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $19.17.

CCAP has been the topic of several analyst reports. LADENBURG THALM/SH SH assumed coverage on Crescent Capital BDC in a research note on Monday, September 30th. They issued a “buy” rating and a $20.00 target price on the stock. Keefe, Bruyette & Woods lifted their price objective on shares of Crescent Capital BDC from $19.00 to $20.00 and gave the stock an “outperform” rating in a research report on Monday, November 25th.

Crescent Capital BDC Trading Up 0.4 %

Shares of NASDAQ:CCAP opened at $19.98 on Friday. The company has a market capitalization of $740.50 million, a PE ratio of 7.84 and a beta of 0.82. The company has a current ratio of 1.26, a quick ratio of 1.26 and a debt-to-equity ratio of 1.14. Crescent Capital BDC has a 12-month low of $15.91 and a 12-month high of $20.03. The business’s fifty day simple moving average is $18.79 and its 200-day simple moving average is $18.65.

Crescent Capital BDC Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Tuesday, December 31st will be issued a dividend of $0.42 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $1.68 annualized dividend and a dividend yield of 8.41%. This is an increase from Crescent Capital BDC’s previous quarterly dividend of $0.07. Crescent Capital BDC’s dividend payout ratio is 65.88%.

Institutional Trading of Crescent Capital BDC

A number of institutional investors have recently bought and sold shares of CCAP. HighTower Advisors LLC increased its stake in Crescent Capital BDC by 0.5% during the 3rd quarter. HighTower Advisors LLC now owns 141,838 shares of the company’s stock valued at $2,624,000 after purchasing an additional 768 shares in the last quarter. Confluence Investment Management LLC increased its position in shares of Crescent Capital BDC by 2.2% in the 3rd quarter. Confluence Investment Management LLC now owns 73,206 shares of the company’s stock valued at $1,354,000 after acquiring an additional 1,583 shares during the period. Point72 Asset Management L.P. acquired a new position in shares of Crescent Capital BDC in the 2nd quarter valued at $90,000. Sumitomo Mitsui Trust Holdings Inc. raised its stake in Crescent Capital BDC by 14.1% in the 2nd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 80,766 shares of the company’s stock worth $1,517,000 after acquiring an additional 10,000 shares during the last quarter. Finally, XTX Topco Ltd acquired a new stake in Crescent Capital BDC during the 2nd quarter worth about $195,000. 49.46% of the stock is currently owned by institutional investors and hedge funds.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.